The Journal of Thoracic and Cardiovascular Surgery
Volume 126, Issue 4 , Pages 947-949 , October 2003

Lymph node involvement in esophageal adenocarcinoma: if you see one, have you seen them all?

  • Steven R. DeMeester, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Keck School of Medicine, the University of Southern California, Los Angeles, Calif, USA
    • Corresponding Author InformationAddress for reprints: Steven R. DeMeester, MD, Assistant Professor of Cardiothoracic Surgery, Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Suite 7418, Los Angeles, CA 90033-0804, USA

Received 1 April 2003 ,Accepted 15 April 2003.

References 

  1. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50:368–372
  2. Nigro JJ, DeMeester SR, Hagen JA, et al.  Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999;117:960–968
  3. Korst RJ, Rusch VW, Venkatraman E, et al.  Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg. 1998;115:660–670
  4. Altorki NMD, Skinner DMD. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg. 2001;234:581–587
  5. Dhar DK, Tachibana M, Kinukawa N, et al.  The prognostic significance of lymph node size in patients with squamous esophageal cancer. Ann Surg Oncol. 2002;9:1010–1016
  6. Roder JD, Busch R, Stein HJ, et al.  Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994;81:410–413
  7. Hagen J, DeMeester S, Peters J, et al.  Curative resection for esophageal adenocarcinoma (analysis of 100 en bloc esophagectomies). Ann Surg. 2001;234:520–531
  8. Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, Fieuws S, et al. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg. 2003;126:1121-8
  9. Rice TW, Zuccaro G, Adelstein DJ, et al.  Esophageal carcinoma (depth of tumor invasion is predictive of regional lymph node status). Ann Thorac Surg. 1998;65:787–792
  10. Bates BA, Detterbeck FC, Bernard SA, et al.  Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol. 1996;14:156–163
  11. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology. 1994;41:391–393
  12. Urba S, Orringer M, Turisi A, et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305–313
  13. Jiao X, Krasna MJ, Sonett J, et al.  Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. Eur J Cardiothorac Surg. 2001;19:880–886
  14. Siewert RJ, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction (results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients). Ann Surg. 2000;232:353–361
  15. Izbicki JR, Hosch SB, Pichlmeier U, et al.  Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188–1194

PII: S0022-5223(03)00732-3

doi: 10.1016/S0022-5223(03)00732-3

The Journal of Thoracic and Cardiovascular Surgery
Volume 126, Issue 4 , Pages 947-949 , October 2003

Article Tools